期刊文献+

新冠疫情前后我国19家省级血液中心血小板成分血生产量研究

Study on platelet components production in 19 provincial blood centers in China before and during the COVID-19 epidemic
原文传递
导出
摘要 目的 研究我国省级血液中心疫情前后血小板成分血生产量、单采血小板采集量和浓缩血小板制备量的变化趋势。方法 收集19家省级血液中心2016—2021年与单采血小板采集量及浓缩血小板制备量相关的数据,分别计算疫情发生之前4年(2016—2019年)及新冠疫情期间(2020年和2021年)血小板成分血的生产量、单采血小板采集量和浓缩血小板制备量,分析其变化趋势。结果 2016—2019年19家血液中心血小板成分血生产总量稳步增长,2020年降低4.16%,2021年增加15.60%,超过疫情前水平。2020年42.11%(8/19)的血液中心血小板成分血的生产量较上一年有所降低,2021年94.74%(18/19)的血液中心血小板成分血的生产量较上一年有所增加。单采血小板采集量变化趋势同血小板成分血生产量趋势基本一致。2017、2018年浓缩血小板制备总量较前一年均翻番;2019年浓缩血小板制备总量较前一年减少了67.98%;2020年增加30.38%,2021下降27.08%。结论 新冠疫情前血小板成分血生产总量稳步增长。受疫情影响,2020年生产总量减少,部分血液中心受到较大冲击。2021年,随着我国防控措施优化,在政府的大力支持和各采供血机构采取的各种有力措施下,血小板成分血的生产总量增加。 Objective To study the changes of platelet components(PC),apheresis platelets(AP)and pooled platelet concentrates(PPC)production of 19 provincial blood centers before and during the COVID-19 epidemic.Methods The data related to the collection of AP and the preparation of PPC from 2016 to 2021 of 19 provincial blood centers was collected.The production of PC,AP and PPC during the four years before the epidemic(i.e.2016-2019)and during the COVID-19 epidemic(i.e.2020 and 2021)were calculated respectively,and the change of production was analyzed.Results The total production of PC in 19 blood centers steadily increased from 2016 to 2019,with a decrease of 4.16%in 2020 and an increase of 15.60%in 2021,exceeding the output before the COVID-19 epidemic.In 2020,the production of PC of 42.11%(8/19)blood centers decreased compared with 2019,while 94.74%(18/19)in 2021 increased compared with 2020.The changes of AP output was basically consistent with the trend of PC.The total production of PPC in 2017 and 2018 both doubled compared to the previous year,while decreased by 67.98%in 2019,increased by 30.38%in 2020 and decreased by 27.08%in 2021.Conclusion The total production of PC kept increasing steadily between 2016 and 2019,but decreased in 2020 under the COVID-19 epidemic,with some blood centers being significantly affected.In 2021,with the strong support from government and various measures by blood centers,the total production of PC increased.
作者 张嫄 陈阳 王林 张志安 李莹 张金彩 罗孟卓 孟慧灵 周娟 杜霞 卢长春 谢英 邓莉 安慧娟 梁社玲 张旸 兰艳 周源 邱艳 ZHANG Yuan;CHEN Yang;WANG Lin;ZHANG Zhian;LI Ying;ZHANG Jincai;LUO Mengzhuo;MENG Huiling;ZHOU Juan;DU Xia;LU Changchun;XIE Ying;DENG Li;AN Huijuan;LIANG Sheling;ZHANG Yang;LAN Yan;ZHOU Yuan;QIU Yan(Shaanxi Blood Center,Xian 710061,China;Liaoning Province Blood Center;Hainan Provincial Blood Center;Wuhan Blood Center;Jiangxi Province Blood Center;Hebei Province Blood Center;Changsha Blood Center;Urumqi Blood Center;Blood Center of Shandong Province;Yunnan Kunming Blood Center;Heilongjiang Blood Center;Gansu Red Cross Blood Center;Chongqing Blood Center;Henan Red Cross Blood Center;Ningxia Blood Center;Guangzhou Blood Center;Inner Mongolia Blood Center;Taiyuan Blood Center;Beijing Red Cross Blood Center.)
出处 《中国输血杂志》 CAS 2023年第10期898-902,共5页 Chinese Journal of Blood Transfusion
基金 陕西省卫健委项目(2021D002) 西安市科技计划项目(21YXYJ0084)。
关键词 新冠疫情 血小板成分血 单采血小板 浓缩血小板 生产量 COVID-19 platelet components apheresis platelet pooled platelet concentrates production
  • 相关文献

参考文献15

二级参考文献118

  • 1陈方若.大疫当前谈供应链思维:从“啤酒游戏”说起[J].中国科学院院刊,2020,0(3):289-296. 被引量:14
  • 2王竞,程雅倩,周照,蒋安妮,郭俊慧,陈振华,万其容.新型冠状病毒肺炎疫情对武汉市一线医护人员心理状况的影响[J].武汉大学学报(医学版),2020(4):547-550. 被引量:94
  • 3杨帆,秦银河,董军.医疗质量评价方法的应用和展望[J].中华医院管理杂志,2005,21(3):172-174. 被引量:19
  • 4刘滨谊,郭璁.通过设计促进健康——美国“设计下的积极生活”计划简介及启示[J].国外城市规划,2006,21(2):60-65. 被引量:26
  • 5Louis T, Annie B, Marie JG,et al. Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method [ J ]. Transfusion, 2006,46 ( 8 ) : 1292--1299
  • 6Moroff G, Kline L, Dabay M, et al. Reevaluation of the resting time period when preparing whole blood-derived platelet concentrates with the platelet-rich plasma tnethod [ J ]. Transfusion,2006,46 (4) :572-577
  • 7AuBuchon JP, Snyder EL. The rationale for a standardized approach to assessment of platelet kinetics [ J ]. Transfusion, 2006, 46(supple) :44s
  • 8Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion ) task force of the international society of blood transfusion [ J ]. Transfus Med Rev, 1994,45 (8) : 29-36
  • 9Sherrill JS, Doug B, Mary KJ,et al. Viability and function of 8- day-stored apheresis platelets [ J ]. Transfusion, 2006,46 ( 10 ) : 1763-1769
  • 10Van der Meer PF,pietersz RNI,Reesink HW. Storage platetets in additive solution for up to 12 days with maintenance of good invitro quality[ J]. Transfusion ,2004,44 (9) : 1204-1211

共引文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部